Abstract:Accurate staging improves lung cancer survival by increasing the chances of delivering stage‐appropriate therapy. However, there is underutilization of, and variability in, the use of guideline‐recommended diagnostic tests used to stage lung cancer. Consequently, the American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) convened the Triage for Appropriate Treatment Task Group—a multidisciplinary expert and stakeholder panel—to identify knowledge and/or resource gaps contributing to guideline‐discordant staging and make recommendations to overcome these gaps. The task group determined the following: Gap 1: facilitators of and barriers to guideline‐concordant staging are incompletely understood; Recommendation 1: identify facilitators of and barriers to guideline‐concordant lung cancer staging; Gap 2: the level of evidence supporting staging algorithms is low‐to‐moderate; Recommendation 2: prioritize comparative‐effectiveness studies evaluating lung cancer staging; Gap 3: guideline recommendations vary across professional societies; Recommendation 3: harmonize guideline recommendations across professional societies; Gap 4: existing databases do not contain sufficient information to measure guideline‐concordant staging; Recommendation 4: augment existing databases with the information required to measure guideline‐concordant staging; Gap 5: health systems do not have a performance feedback mechanism for lung cancer staging; Recommendation 5: develop and implement a performance feedback mechanism for lung cancer staging; Gap 6: patients rarely self‐advocate for guideline‐concordant staging; Recommendation 6: increase opportunities for patient self‐advocacy for guideline‐concordant staging; and Gap 7: current health policies do not motivate guideline‐concordant lung cancer staging; Recommendation 7: organize a representative working group under the ACS NLCRT that promotes policies that motivate guideline‐concordant lung cancer staging. Plain language summary Staging—determining the degree of cancer spread—is important because it helps clinicians choose the best cancer treatment. Receiving the best cancer treatment leads to the best possible patient outcomes. Practice guidelines are intended to help clinicians stage patients with lung cancer. However, lung cancer staging in the United States often varies from practice guideline recommendations. This report identifies seven opportunities to improve lung cancer staging.

Seventh edition of the cancer staging manual and stage grouping of lung cancer: quick reference chart and diagrams

The Eighth Edition of TNM Staging of Lung Cancer: Reference Chart and Diagrams

Imaging Understanding of the Updates of the Classification for Pancreatic Cancer in the American Joint Committee on Cancer Cancer Staging Manual (8th Edition)

Imaging of Lung Cancer Staging

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

American Joint Committee on Cancer's Staging System for Breast Cancer, Eighth Edition: What the Radiologist Needs to Know

Evaluation of the 7th Edition of the TNM Classification for Lung Cancer at a Single Institution.

Imaging in Lung Cancer Staging

The Union for International Cancer Control (UICC) and the American Joint Committee on Cancer (AJCC) gastric cancer TNM staging system (8th edition) explanation and elaboration

The new 8th TNM staging system of lung cancer and its potential imaging interpretation pitfalls and limitations with CT image demonstrations

American Joint Committee on Cancer's Staging System for Breast Cancer, Eighth Edition: Summary for Clinicians

[Introduction to the 9th edition of TNM classification for lung cancer]

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revisions of the T-Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer

Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non–small-cell Lung Cancer

The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer

The American Cancer Society National Lung Cancer Roundtable strategic plan: Promoting guideline‐concordant lung cancer staging

Validation of the American Joint Commission on Cancer (8th Edition) Changes for Patients with Stage III Gastric Cancer: Survival Analysis of a Large Series from a Specialized Eastern Center.

TNM classification of malignant tumors (Breast Cancer Study Group)